Bedside whole-blood clotting times: Validity after snakebites

Damien Punguyire, Kenneth V. Iserson, Uwe Stolz, Stephen Apanga

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Venomous snakebites contribute to morbidity and mortality throughout the world, most commonly in resource-poor areas, with about 2.5 million humans sustaining snakebites annually. Coagulopathy is a significant cause of both morbidity and mortality in these patients. In the absence of more sophisticated hematological studies or obvious physical findings, many clinicians must rely on whole-blood clotting times to assess whether their patients are coagulopathic. Alternative (bedside) methods to assess clotting times are often officially recommended and used, but have not been validated. Objective: We assessed two bedside methods for measuring whole-blood clotting time after snakebites for their congruence with results from a hospital laboratory. Methods: Over a 5-month period, 46 sequential patients presenting with a possible snakebite had blood drawn for bedside (using syringe and ceftriaxone bottle as containers) and laboratory whole-blood clotting tests. All three tests used ∼5 mL whole blood and looked for any clot formation within 20 min. Results: Compared to the laboratory, the syringe method correctly classified the patients 84.7% of the time (sensitivity 88.9%; specificity 82.4%). The bottle method correctly classified the patients 86.8% of the time (sensitivity 83.3%; specificity 90.0%). Comparing the area under the Receiver Operator Characteristics curves shows that both the syringe and bottle methods do not differ in their discrimination for identifying clotting. Conclusions: Both the syringe and ceftriaxone bottle bedside clotting test methods appear to be accurate enough to help guide therapy after potential snake envenomations when formal laboratory testing is unavailable.

Original languageEnglish (US)
Pages (from-to)663-667
Number of pages5
JournalJournal of Emergency Medicine
Volume44
Issue number3
DOIs
StatePublished - Mar 2013

Fingerprint

Snake Bites
Blood Coagulation
Syringes
Ceftriaxone
Morbidity
Hospital Laboratories
Mortality
Hematologic Tests

Keywords

  • bedside laboratory testing
  • clotting time
  • coagulopathy
  • envenomation
  • snakebite

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Bedside whole-blood clotting times : Validity after snakebites. / Punguyire, Damien; Iserson, Kenneth V.; Stolz, Uwe; Apanga, Stephen.

In: Journal of Emergency Medicine, Vol. 44, No. 3, 03.2013, p. 663-667.

Research output: Contribution to journalArticle

Punguyire, Damien ; Iserson, Kenneth V. ; Stolz, Uwe ; Apanga, Stephen. / Bedside whole-blood clotting times : Validity after snakebites. In: Journal of Emergency Medicine. 2013 ; Vol. 44, No. 3. pp. 663-667.
@article{a33ccc8891234cebab10e9790a2a4f88,
title = "Bedside whole-blood clotting times: Validity after snakebites",
abstract = "Background: Venomous snakebites contribute to morbidity and mortality throughout the world, most commonly in resource-poor areas, with about 2.5 million humans sustaining snakebites annually. Coagulopathy is a significant cause of both morbidity and mortality in these patients. In the absence of more sophisticated hematological studies or obvious physical findings, many clinicians must rely on whole-blood clotting times to assess whether their patients are coagulopathic. Alternative (bedside) methods to assess clotting times are often officially recommended and used, but have not been validated. Objective: We assessed two bedside methods for measuring whole-blood clotting time after snakebites for their congruence with results from a hospital laboratory. Methods: Over a 5-month period, 46 sequential patients presenting with a possible snakebite had blood drawn for bedside (using syringe and ceftriaxone bottle as containers) and laboratory whole-blood clotting tests. All three tests used ∼5 mL whole blood and looked for any clot formation within 20 min. Results: Compared to the laboratory, the syringe method correctly classified the patients 84.7{\%} of the time (sensitivity 88.9{\%}; specificity 82.4{\%}). The bottle method correctly classified the patients 86.8{\%} of the time (sensitivity 83.3{\%}; specificity 90.0{\%}). Comparing the area under the Receiver Operator Characteristics curves shows that both the syringe and bottle methods do not differ in their discrimination for identifying clotting. Conclusions: Both the syringe and ceftriaxone bottle bedside clotting test methods appear to be accurate enough to help guide therapy after potential snake envenomations when formal laboratory testing is unavailable.",
keywords = "bedside laboratory testing, clotting time, coagulopathy, envenomation, snakebite",
author = "Damien Punguyire and Iserson, {Kenneth V.} and Uwe Stolz and Stephen Apanga",
year = "2013",
month = "3",
doi = "10.1016/j.jemermed.2012.07.073",
language = "English (US)",
volume = "44",
pages = "663--667",
journal = "Journal of Emergency Medicine",
issn = "0736-4679",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Bedside whole-blood clotting times

T2 - Validity after snakebites

AU - Punguyire, Damien

AU - Iserson, Kenneth V.

AU - Stolz, Uwe

AU - Apanga, Stephen

PY - 2013/3

Y1 - 2013/3

N2 - Background: Venomous snakebites contribute to morbidity and mortality throughout the world, most commonly in resource-poor areas, with about 2.5 million humans sustaining snakebites annually. Coagulopathy is a significant cause of both morbidity and mortality in these patients. In the absence of more sophisticated hematological studies or obvious physical findings, many clinicians must rely on whole-blood clotting times to assess whether their patients are coagulopathic. Alternative (bedside) methods to assess clotting times are often officially recommended and used, but have not been validated. Objective: We assessed two bedside methods for measuring whole-blood clotting time after snakebites for their congruence with results from a hospital laboratory. Methods: Over a 5-month period, 46 sequential patients presenting with a possible snakebite had blood drawn for bedside (using syringe and ceftriaxone bottle as containers) and laboratory whole-blood clotting tests. All three tests used ∼5 mL whole blood and looked for any clot formation within 20 min. Results: Compared to the laboratory, the syringe method correctly classified the patients 84.7% of the time (sensitivity 88.9%; specificity 82.4%). The bottle method correctly classified the patients 86.8% of the time (sensitivity 83.3%; specificity 90.0%). Comparing the area under the Receiver Operator Characteristics curves shows that both the syringe and bottle methods do not differ in their discrimination for identifying clotting. Conclusions: Both the syringe and ceftriaxone bottle bedside clotting test methods appear to be accurate enough to help guide therapy after potential snake envenomations when formal laboratory testing is unavailable.

AB - Background: Venomous snakebites contribute to morbidity and mortality throughout the world, most commonly in resource-poor areas, with about 2.5 million humans sustaining snakebites annually. Coagulopathy is a significant cause of both morbidity and mortality in these patients. In the absence of more sophisticated hematological studies or obvious physical findings, many clinicians must rely on whole-blood clotting times to assess whether their patients are coagulopathic. Alternative (bedside) methods to assess clotting times are often officially recommended and used, but have not been validated. Objective: We assessed two bedside methods for measuring whole-blood clotting time after snakebites for their congruence with results from a hospital laboratory. Methods: Over a 5-month period, 46 sequential patients presenting with a possible snakebite had blood drawn for bedside (using syringe and ceftriaxone bottle as containers) and laboratory whole-blood clotting tests. All three tests used ∼5 mL whole blood and looked for any clot formation within 20 min. Results: Compared to the laboratory, the syringe method correctly classified the patients 84.7% of the time (sensitivity 88.9%; specificity 82.4%). The bottle method correctly classified the patients 86.8% of the time (sensitivity 83.3%; specificity 90.0%). Comparing the area under the Receiver Operator Characteristics curves shows that both the syringe and bottle methods do not differ in their discrimination for identifying clotting. Conclusions: Both the syringe and ceftriaxone bottle bedside clotting test methods appear to be accurate enough to help guide therapy after potential snake envenomations when formal laboratory testing is unavailable.

KW - bedside laboratory testing

KW - clotting time

KW - coagulopathy

KW - envenomation

KW - snakebite

UR - http://www.scopus.com/inward/record.url?scp=84875366185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875366185&partnerID=8YFLogxK

U2 - 10.1016/j.jemermed.2012.07.073

DO - 10.1016/j.jemermed.2012.07.073

M3 - Article

C2 - 23047197

AN - SCOPUS:84875366185

VL - 44

SP - 663

EP - 667

JO - Journal of Emergency Medicine

JF - Journal of Emergency Medicine

SN - 0736-4679

IS - 3

ER -